Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Current Pediatric Reviews
  4. Volume 21, Issue 2
  5. Article
Volume 21, Issue 2
  • ISSN: 1573-3963
  • E-ISSN: 1875-6336

Abstract

Background

To date, few studies have compared the effectiveness of exogenous surfactant therapy with Curosurf and Beraksurf in the treatment of respiratory distress syndrome (RDS) in preterm neonates.

Objective

Since surfactant has a significant impact on the treatment of neonates with RDS, this study was conducted to introduce a more effective method for treating preterm neonates with RDS.

Methods

The present clinical trial was conducted on 140 preterm neonates with RDS in the NICU department of two specialized university hospitals in Hamadan, western Iran. In one group, we used the Iranian-made surfactant Beraksurf, and in another group, we used the Italian-made surfactant Curosurf. In the end, the checklist for the two groups was completed. Data analysis was performed using SPSS version 22, and a significance level of 5% was considered for all tests.

Results

The comparison of the frequency distribution of maternal corticosteroid administration, response to treatment and need for re-intubation, associated disorders, and mortality among neonates of the two groups of Beracsurf and Curosurf surfactant did not show a significant difference (p=0.962, 0.763, 0.725 and 0.149, respectively). Further, the comparison of the mean number of days requiring respiratory support, days free from respiratory support, and hospitalization days among neonates of the two groups of Beracsurf and Curosurf surfactant injection did not show a significant difference (p=0.910, 0.725, and 0.898, respectively). Additionally, the comparison of the time of initiation of feeding and the time of reaching maximum feeding among neonates of the two groups of Beracsurf and Curosurf surfactant injection also did not show significant differences (p=0.881 and 0.903, respectively).

Conclusion

Based on the fact that Beracsurf and Curosurf surfactants did not show significant differences in the treatment outcomes of RDS in preterm neonates, it is suggested that the Iranian- made surfactant, Beracsurf, should be used for the treatment of these neonates due to its cost-effectiveness and availability compared to Curosurf.

Clinical Trial Registration Number

IRCT20200812048381N1.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cpr/10.2174/0115733963271143240403070529
2024-04-15
2024-12-25

  • From This Site

    /content/journals/cpr/10.2174/0115733963271143240403070529
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. BeckS. WojdylaD. SayL. BertranP.A. MeraldiM. RequejoH.J. RubensC. MenonR. LookV.P. The worldwide incidence of preterm birth: A systematic review of maternal mortality and morbidity.Bull. World Health Organ.2010881313810.2471/BLT.08.06255420428351
     [Google Scholar]
  2. GoldenbergR.L. CulhaneJ.F. IamsJ.D. RomeroR. Epidemiology and causes of preterm birth.Lancet20083719606758410.1016/S0140‑6736(08)60074‑418177778
     [Google Scholar]
  3. GarianoR.F. GardnerT.W. Retinal angiogenesis in development and disease.Nature2005438707096096610.1038/nature0448216355161
     [Google Scholar]
  4. StittA.W. LoisN. MedinaR.J. AdamsonP. CurtisT.M. Advances in our understanding of diabetic retinopathy.Clin. Sci.2013125111710.1042/CS2012058823485060
     [Google Scholar]
  5. RobertsG.E. LacatusuD.A. KesterJ. MoumoutjisF.G. SidiqiM. Preventative management of sepsis-induced acute respiratory distress syndrome in the geriatric population.Cureus2023152e3468010.7759/cureus.3468036909040
     [Google Scholar]
  6. MiallL. Fanaroff and martin's neonatal-perinatal medicine – diseases of the fetus and infant.Seminars Fetal Neonat. Med.2015204P281
     [Google Scholar]
  7. AlthouseLA StockmanJA Pediatric workforce: A look at neonatal-perinatal medicine data from the american board of pediatrics.J Pediatr.2006148672772910.1016/j.jpeds.2006.03.046
     [Google Scholar]
  8. SegerN. SollR. GroupC.N. Animal derived surfactant extract for treatment of respiratory distress syndrome.Cochrane Libr.200920102CD00783610.1002/14651858.CD00783619370695
     [Google Scholar]
  9. VictorinL.H. DeverajanL.V. CurstedtT. RobertsonB. Surfactant replacement in spontaneously breathing babies with hyaline membrane disease-A pilot study.Neonatology199058312112610.1159/0002432502279046
     [Google Scholar]
  10. BjörklundL.J. IngimarssonJ. CurstedtT. JohnJ. RobertsonB. WernerO. VilstrupC.T. Manual ventilation with a few large breaths at birth compromises the therapeutic effect of subsequent surfactant replacement in immature lambs.Pediatr. Res.199742334835510.1203/00006450‑199709000‑000169284276
     [Google Scholar]
  11. StollB.J. HansenN.I. BellE.F. WalshM.C. CarloW.A. ShankaranS. LaptookA.R. SánchezP.J. MeursV.K.P. WyckoffM. DasA. HaleE.C. BallM.B. NewmanN.S. SchiblerK. PoindexterB.B. KennedyK.A. CottenC.M. WatterbergK.L. D’AngioC.T. DeMauroS.B. TruogW.E. DevaskarU. HigginsR.D. Trends in care practices, morbidity, and mortality of extremely preterm neonates, 1993-2012.JAMA2015314101039105110.1001/jama.2015.1024426348753
     [Google Scholar]
  12. SollR BlancoF Natural surfactant extract versus synthetic surfactant for neonatal respiratory distress syndrome.Cochrane Database Syst Rev.201520012CD000144
     [Google Scholar]
  13. SinghN HallidayHL StevensTP SureshG SollR ReyesR.MX Comparison of animal-derived surfactants for the prevention and treatment of respiratory distress syndrome in preterm infants.Cochrane Database Syst Rev.2015201512CD01024910.1002/14651858.CD010249.pub2
     [Google Scholar]
  14. GharehbaghiM.M. SarbakhshP. MohammadbagerH. GharibzadehS. ShasebE.A. Randomized, single-blind, comparison trial of beractant (beraksurftm) versus poractant alfa (curosurf®) in the treatment of respiratory distress syndrome in preterm infants.Pharm. Sci.20222915258
     [Google Scholar]
  15. MohammadiD.P. Comparing the effectiveness of curosurf and beraksurf in the treatment of respiratory distress in premature infants.Int J Pediatr20201051599215997
     [Google Scholar]
  16. GharehbaghiM.M. SakhaS.H.P. GhojazadehM. FirooziF. Complications among premature neonates treated with beractant and poractant alfa.Indian J. Pediatr.201077775175410.1007/s12098‑010‑0097‑y20589459
     [Google Scholar]
  17. AkarS. TopcuogluS. DincerE. OzalkayaE. KaratekinG. YildirimT.G. Comparison of efficacy of beractant and poractant treatment performed with minimal invasive technique.Iranian J. Nematol.202112116
     [Google Scholar]
  18. SaeidiR. HamediA. JavadiA. RobatsangiG.M. DinparvarS.K. Comparison of side effect of survanta and curosurf in decreasing mortality due to respiratory distress syndrome (RDS) in premature infants admitted in NICU of Ghaem Hospital On 2006-2008.Iran J Neonatol.201343712
     [Google Scholar]
  19. MussaviM. MirniaK. AsadollahiK. Comparison of the efficacy of three natural surfactants (Curosurf, Survanta, and Alveofact) in the treatment of respiratory distress syndrome among neonates: A randomized controlled trial.Iran. J. Pediatr.2016In PressIn Presse574310.5812/ijp.574328203337
     [Google Scholar]
  20. RamanathanR. RasmussenM.R. GerstmannD.R. FinerN. SekarK. A randomized, multicenter masked comparison trial of poractant alfa (Curosurf) versus beractant (Survanta) in the treatment of respiratory distress syndrome in preterm infants.Am. J. Perinatol.200421310911910.1055/s‑2004‑82377915085492
     [Google Scholar]
  21. DilliD. ÇakmakçıE. AkdumanH. OktemA. AydoğanS. ÇitliR. ZenciroğluA. Comparison of three natural surfactants according to lung ultrasonography scores in newborns with respiratory distress syndrome.J. Matern. Fetal Neonatal Med.202134101634164010.1080/14767058.2019.164331331296073
     [Google Scholar]
  22. ŞimşekK.G. KutmanK.H.G. CanpolatF.E. OğuzŞ.S. Effect of two different early rescue surfactant treatments on mortality in preterm infants with respiratory distress syndrome.Clin. Respir. J.202014328529010.1111/crj.1313031814293
     [Google Scholar]
  23. BaskeS. SahaS. PalP.P. Comparison between two natural surfactant poractant alfa and bovine lipid extract in respiratory distress syndrome amongst preterm neonates-a quasi-experimental study.Int. J. Contemp. Pediatrics2021912710.18203/2349‑3291.ijcp20214848
     [Google Scholar]
  24. RamanathanR BiniwaleM SekarK HannaN GolombekS BhatiaJ Synthetic surfactant CHF5633 compared with poractant alfa in the treatment of neonatal respiratory distress syndrome: A multicenter, double-blind, randomized, controlled clinical trial.J Pediatr.20202259096.e110.1016/j.jpeds.2020.06.024
     [Google Scholar]
/content/journals/cpr/10.2174/0115733963271143240403070529
Loading
Comparison of the Effectiveness of Beraksurf and Curosurf Exogenous Surfactants in the Treatment of Respiratory Distress Syndrome in Preterm Neonates: A Double-blind Randomized Study in the West of Iran
Curr Pediatr Rev 21, 200 (2025); https://doi.org/10.2174/0115733963271143240403070529
/content/journals/cpr/10.2174/0115733963271143240403070529
/content/journals/cpr/10.2174/0115733963271143240403070529
Loading

Data & Media loading...


  • Article Type:     Research Article
Keyword(s): double-blind randomized study; Iran; neonate; preterm; respiratory distress syndrome; Surfactant

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test